Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R

Healthcare Biotechnology


TSX:CXR.R - Post by User

Concordia Healthcare Corp. > TSX Down 4.26% on the week...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by argentia77on Dec 13, 2015 6:49pm
114 Views
Post# 24381485

RE:RE:RE:RE:TSX Down 4.26% on the week...

RE:RE:RE:RE:TSX Down 4.26% on the week...

greenpasture wrote: Just a cycle and time of year. Check out the markets last year. Next week the Dow rebounds and we all will be in rally mode again. Money flowing into the US dollar will not stop given the problems in Europe. Healthcare and Pharmaceuticals, best defensive plays for years to come and CXR, NHC, CPH are my picks for 2016/2017 .



PLI up 125% since end of September. More tomorrow: ProMetic to disclose new PBI-4050 orphan indication and hold conference call / webcast
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities